WOCKHARDT
Back to Balance Sheet
|
WOCKHARDT Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹2,043 Cr | ₹2,791 Cr | ₹3,435 Cr | ₹3,207 Cr | ₹3,121 Cr |
What is the latest Total Current Liabilities ratio of WOCKHARDT ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹2,043 Cr |
| Mar2024 | ₹2,791 Cr |
| Mar2023 | ₹3,435 Cr |
| Mar2022 | ₹3,207 Cr |
| Mar2021 | ₹3,121 Cr |
How is Total Current Liabilities of WOCKHARDT Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,043 Cr | -26.80 | |
| Mar2024 | ₹2,791 Cr | -18.75 | |
| Mar2023 | ₹3,435 Cr | 7.11 | |
| Mar2022 | ₹3,207 Cr | 2.76 | |
| Mar2021 | ₹3,121 Cr | - | |
Compare Total Current Liabilities of peers of WOCKHARDT
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WOCKHARDT | ₹22,170.7 Cr | -2.3% | 1.4% | -2.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,613.0 Cr | 0.9% | 6.2% | 0.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,105.0 Cr | 1.8% | 4.8% | 6.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,926.0 Cr | 1.3% | 9.8% | 37.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,088.0 Cr | 1.7% | 5.8% | 6.7% | Stock Analytics | |
| CIPLA | ₹107,120.0 Cr | -1.3% | 0.9% | -8.9% | Stock Analytics | |
WOCKHARDT Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WOCKHARDT | -2.3% |
1.4% |
-2.1% |
| SENSEX | 0% |
1.2% |
9.7% |
You may also like the below Video Courses